vimarsana.com

Latest Breaking News On - Institute of nuclear medicine - Page 18 : vimarsana.com

DRDO issues directions on usage of anti-coronavirus drug 2-DG on patients

Read more about DRDO issues directions on usage of anti-coronavirus drug 2-DG on patients on Business Standard. The DRDO issued directions on the usage of its 2-DG drug on COVID-19 patients, stating that caution should be exercised while prescribing this medicine to people who have comorbidites

India
Harsh-vardhan
Rajnath-singh
Twitter
Institute-of-nuclear-medicine
Development-organisation
Defence-research
Drugs-controller-general
Defence-minister-rajnath-singh
Health-minister-harsh
Nuclear-medicine
Allied-sciences

DRDO issues usage directions for 2DG, here's how you should consume the prescription drug

URL copied 2-DG: How and when to use DRDO s anti-Covid drug? Guidelines Defence Research and Development Organisation (DRDO) on Tuesday released guidelines on how and when to use its anti-Covid medicine 2-Deoxy-d-glucose (2-DG) medicine. The drug was launched last month by the Ministry of Defence. It has been developed by the Institute of Nuclear Medicine and Allied Sciences (INMAS), a leading laboratory of the DRDO, in collaboration with Dr Reddy s Laboratories (DRL) in Hyderabad. The DRDO said that 2-DG medicine should be used under the supervision of a doctor. The oral drug for emergency use is an adjunct therapy to treat severe Covid patients. It reduces dependence on supplemental oxygen.

Hyderabad
Andhra-pradesh
India
Rajnath-singh
Reddy-lab
Institute-of-nuclear-medicine
Ministry-of-defence
Development-organisation
Defence-research
Image-source
Nuclear-medicine
Allied-sciences

DRDO issues directions on usage of anti-Covid drug 2-DG | India News

India News: The DRDO on Tuesday issued directions on the usage of its 2-DG drug on Covid-19 patients, stating that caution should be exercised while prescribing t

India
Harsh-vardhan
Rajnath-singh
Twitter
Institute-of-nuclear-medicine
Development-organisation
Defence-research
Drugs-controller-general
Nuclear-medicine
Allied-sciences
Ndia-news
Ndia-news-today

2DG approved for emergency use as adjunct therapy for Covid-19 patients: DRDO | India News

Pic credit: ANI NEW DELHI: The Defence Research and Development Organisation s (DRDO) on Tuesday said that the anti-Covid drug 2DG is approved for emergency use as an adjunct therapy to the standard of care in the treatment of coronavirus patients in hospital settings. The DRDO said that anti-Covid drug 2DG can now be given to Covid 19 patients under the care and prescription of doctors. DRDO also issued some important guidelines with regard to its anti-Covid -19 drug. Ideally, 2DG should be prescribed as early as possible by doctors for moderate to severe Covid patients for a maximum duration of up to 10 days, it said.

Hyderabad
Andhra-pradesh
India
Rajnath-singh
Centre-for-cellular
Institute-of-nuclear-medicine
Development-organisation
Defence-research
Defence-minister-rajnath-singh
Drugs-controller-general
Nuclear-medicine
Allied-sciences

What's The Price of DRDO 2DG Oral Antiviral Drug for COVID

Dr Reddy's Labarotaries has announced the price of 2-DG drug for Covid-19 patients at Rs 990 per sachet, developed by DRDO in collaboration with Dr Reddys. Government hospitals, central and state governments would be provided with the medicine at a discounted price, said an official. This drug is available in powder form and can be consumed orally by dissolving it in water.

India
Reddy-labarotaries
Institute-of-nuclear-medicine
Development-organisation
Defence-research
Nuclear-medicine
Allied-sciences
Drugs-controller-general
2-dg
Drdo-covid-drug-price
2-dg-covid-price
Coronavirus

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.